Surgery for Relapsed Ovarian Cancer: When Should it Be Offered?
- First Online:
- Cite this article as:
- Harter, P., Heitz, F. & du Bois, A. Curr Oncol Rep (2012) 14: 539. doi:10.1007/s11912-012-0260-x
- 277 Downloads
Whilst cytoreductive surgery is the mainstay treatment for primary ovarian cancer, its role in relapse is still unclear. Surgery in platinum-sensitive recurrent ovarian cancer might be beneficial if it results in complete resection of the disease. Clinical scores could help to identify suitable patients. Level I evidence is still missing; however, two randomized trials (DESKTOP III and GOG 213) are ongoing.